Solabia Nutrition announces the start of the Dermaphenolics Project Collaboration with Radboud University Medical Center

Press Release

Maastricht/Nijmegen, The Netherlands, 13th June 2024

About the Dermaphenolics Project

Solabia Nutrition announces the start of a collaboration around the Dermaphenolics project with Radboud University Medical Center (RUMC), whereby RUMC’s deep understanding of cellular signaling and skin health is combined with Solabia Nutrition’s pipeline of clinical leads.

Solabia Nutrition has expertise and experience in the clinical development of innovative active ingredients, extracted from plants (botanicals) with great potential for women’s health, cognitive function, healthy aging and gut-skin axis.

RUMC is affiliated with Radboud University in the Netherlands, and is a leading institution in dermatology, both for patient care and mechanistic research in the field of skin biology.

The objective of this project is to study the effect of phenolics on in-vitro cultures of skin cells. The project will focus on keratinocyte cellular signaling and skin homeostasis. These phenolic compounds are currently being studied by Solabia Nutrition in exploratory clinical studies for multiple endpoints, including endpoints related to skin physiology.

Solabia Nutrition’s head of R&D Yala Stevens takes the lead in this collaboration together with Prof. Ellen van den Bogaard, the head of the Laboratory for Experimental Dermatology.

Yala Stevens, head of R&D at Solabia Nutrition, comments:

“This is a great first step in understanding the impact that our phenolic lead compounds could have on skin cells and skin homeostasis. The Dermophenolics Project will allow us to get mechanistic insights in the area of skin biology and be the basis for further clinical validation.”